Turmeric and skin spots
What the WDTE60N study showed about instrument-measured facial spot intensity.
Key points
- In a study of healthy women aged 18–40 with facial spots, instrument-measured spot intensity decreased by 2.28% with WDTE60N versus 0.31% with placebo over 60 days. When choosing a supplement, consider the preliminary signal for facial spots and that whether the change is noticeable to a person has not been established. [1] See the evidence 1
- The trial used the specific oral product WDTE60N; other extracts and spice have different compositions. When comparing products, check the studied form. [1] [2] See the evidence 1 2
Practical guide
Check the conclusions and whether they apply to your situation.
The study assessed a specific extract and an instrument measure.
Key points
Why these conclusions
The WDTE60N study
Healthy women aged 18–40 with facial spots took 250 mg WDTE60N orally daily, containing 150 mg curcuminoids, or placebo for 60 days. Instrument-measured spot intensity decreased 2.28% versus 0.31%; whether a person notices the change has not been established. [1]
Curcuma longa rhizome powder, curcumin, standardized extracts and formulas with piperine have different compositions; results for a specific product apply to its form. [2]
After 60 days, instrument-measured spot intensity decreased 2.28% with WDTE60N versus 0.31% with placebo in 90 women who completed the study.
| Parameter | Data |
|---|---|
| Result | After 60 days, instrument-measured spot intensity decreased 2.28% with WDTE60N versus 0.31% with placebo in 90 women who completed the study. Reduction in instrument-measured spot intensity from baseline: 2.28% versus 0.31% by day 60. |
| Participants | 96 healthy women aged 18–40 with facial spots, 45 and 45 completed |
| Form | Oral water-dispersible extract WDTE60N |
| Dose | 250 mg/day, 150 mg curcuminoids |
| Dose basis | 250 mg/day, 150 mg curcuminoids |
| Comparator | placebo |
| Duration | 60 days |
| Confidence | 1/4: Precision: Contrast confidence interval not extracted. Consistency: No grounds for a separate downgrade. Applicability to the specified group: One instrument measure for a specific product. Possible publication bias: No specific data for a separate downgrade. Study methods: Dropouts, manufacturer and multiple outcomes. |
| Evidence base | 1 randomized trial (96 randomized, 90 completed; both skin measures are from one trial) |
| Sources | [1] |
Curcuma longa rhizome powder, curcumin, standardized extracts and formulas with piperine have different compositions; results for a specific product apply to its form.
Curcuma longa rhizome powder, curcumin, standardized extracts and formulas with piperine have different compositions; results for a specific product apply to its form. [2]
Sources
- Efficacy and Safety of an Oral Low-Dose Water-Dispersible Turmeric Extract Capsule on Facial Skin Health in Healthy Women: A Randomized, Double-Blind, Placebo-Controlled Trial. https://pmc.ncbi.nlm.nih.gov/articles/PMC12448269/
- NCCIH Turmeric: Usefulness and Safety. https://www.nccih.nih.gov/health/turmeric
Methodology: Subpages evidence-led supplement pipeline v1